Molecular Quality Controls Market | Infectious Disease Diagnostics is expected to drive growth in the coming years

According to the market research report by Future Market Insights, the global Molecular Quality Controls Market is estimated to increase at a CAGR of 6.7%, from US$ 164 million in 2021 to US$ 226 million by 2026.

Request for Report Sample@
https://www.futuremarketinsights.com/reports/sample/rep-gb-14301

Rising third-party quality control adoption, a growing number of accredited clinical laboratories, rising demand for external quality assessment support, rising government funding to support genomics projects, rising demand for personalised medicines, declining sequencing costs, and rising prevalence of infectious diseases, cancer, and genetic diseases are all propelling the molecular quality controls market forward.

The COVID-19 pandemic harmed the sales of molecular quality controls. As governments relax their restrictions on migration, the number of people who are tested is increasing.

With the COVID-19 pandemic, dealing with infectious diseases has become a major medical concern worldwide. The demand for more precise and simple testing methods, as well as the expansion of testing structures, is increasing. Companies have also made strategic decisions to deploy COVID-19 quick testing, maintain revenue, and reduce the impact of COVID-19 on their operational capabilities.

The number of laboratory tests performed has increased as the global burden of various diseases has increased. To meet this demand, the number of laboratories in both the public and private sectors is increasing.

Setting up a quality control process in a clinical laboratory requires a significant financial investment. Laboratories also require specialised personnel to oversee the quality control system.

QC procedures incur the same costs regardless of the number of tests completed. As a result, the cost of implementing quality control processes in clinical laboratories that perform a small number of diagnostic tests is prohibitively expensive. This, combined with funding constraints in many hospitals and laboratories in both developed and emerging economies, is expected to reduce the use of quality-control techniques.

As a result of technological advancements, new multi-analyte and multi-instrument controls have been developed. Many instrument-specific controls are combined into a single control in these cutting-edge controls, allowing clinical laboratories to save money. Furthermore, by eliminating the need for separate QC processes for each analyte, these controls save time.

In the next years, the increased availability of such molecular quality controls for infectious disease diagnostics and other applications is likely to drive market expansion.

We Offer tailor-made Solutions to fit Your Requirements, Request Customization@
https://www.futuremarketinsights.com/customization-available/rep-gb-14301

Key Takeaways:

• The Asia Pacific molecular quality controls market is expected to reach US$ 72.07 million in 2028 from US$ 34.27 million in 2021; it is estimated to grow at a CAGR of 11.2%.
• The European molecular quality controls market is expected to reach US$ 109.59 million by 2028 from US$ 55.76 million in 2021; it is estimated to grow at a CAGR of 10.1%.
• The growing implementation of genomic sequencing in healthcare systems is supported by substantial government investments, totaling over US$ 4 billion by at least 14 countries.

Key Segments
  By Analyte:

• Single-analyte Controls
• Multi-analyte Controls

  By Product Type:

• Independent controls
• Instrument-specific controls

  By Application:

• Infectious Diseases Diagnostics
• Oncology Testing and Genetic testing

  By End User:

• Diagnostic laboratories
• Hospitals
• IVD manufacturer & CROs
• Academic & Research Institutes

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs